Indaptus Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Indaptus Therapeutics Total Assets Growth & History (INDP)
Indaptus Therapeutics's total assets was $9.3M for fiscal 2025.
View full Indaptus Therapeutics company overviewIndaptus Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.3M | $2.0M | +26.86% |
| 2024 | 2024-12-31 | $7.3M | −$7.6M | −50.83% |
| 2023 | 2023-12-31 | $14.9M | −$13.1M | −46.82% |
| 2022 | 2022-12-31 | $28.1M | −$12.5M | −30.84% |
| 2021 | 2021-12-31 | $40.6M | $38.8M | +2182.41% |
| 2020 | 2020-12-31 | $1.8M | — | — |
Indaptus Therapeutics quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $12.0M | $5.1M | +75.28% |
| Q1 2026 | 2026-03-31 | $2.2M | −$3.2M | −59.70% |
| Q4 2025 | 2025-12-31 | $9.3M | $2.0M | +26.86% |
| Q3 2025 | 2025-09-30 | $6.8M | −$1.4M | −16.99% |
| Q2 2025 | 2025-06-30 | $6.8M | −$1.3M | −15.79% |
| Q1 2025 | 2025-03-31 | $5.4M | −$5.5M | −50.57% |
| Q4 2024 | 2024-12-31 | $7.3M | −$7.6M | −50.83% |
| Q3 2024 | 2024-09-30 | $8.2M | −$9.6M | −53.69% |
| Q2 2024 | 2024-06-30 | $8.1M | −$12.7M | −61.04% |
| Q1 2024 | 2024-03-31 | $10.9M | −$12.2M | −52.70% |
| Q4 2023 | 2023-12-31 | $14.9M | −$13.1M | −46.82% |
| Q3 2023 | 2023-09-30 | $17.8M | −$12.7M | −41.57% |
| Q2 2023 | 2023-06-30 | $20.8M | −$13.2M | −38.80% |
| Q1 2023 | 2023-03-31 | $23.1M | −$13.9M | −37.59% |
| Q4 2022 | 2022-12-31 | $28.1M | −$12.5M | −30.84% |
| Q3 2022 | 2022-09-30 | $30.5M | −$13.4M | −30.57% |
| Q2 2022 | 2022-06-30 | $34.1M | $14.0M | +69.52% |
| Q1 2022 | 2022-03-31 | $37.1M | — | — |
| Q4 2021 | 2021-12-31 | $40.6M | $38.8M | +2182.41% |
| Q3 2021 | 2021-09-30 | $43.9M | — | — |
| Q2 2021 | 2021-06-30 | $20.1M | — | — |
| Q4 2020 | 2020-12-31 | $1.8M | — | — |
Indaptus Therapeutics total assets trends
Over the last five fiscal years, Indaptus Therapeutics's total assets increased from $1.8M to $9.3M, a change of $7.5M. The latest reported quarter, Q2 2026, shows $12.0M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Indaptus Therapeutics source filings ↗